Mckesson Corp
F:MCK

Watchlist Manager
Mckesson Corp Logo
Mckesson Corp
F:MCK
Watchlist
Price: 718.8 EUR 3.57% Market Closed
Market Cap: €89.4B

Gross Margin

3.5%
Current
Declining
by 0.5%
vs 3-y average of 3.9%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
3.5%
=
Gross Profit
$13.4B
/
Revenue
$387.1B

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
3.5%
=
Gross Profit
€13.4B
/
Revenue
$387.1B

Peer Comparison

Country Company Market Cap Gross
Margin
US
Mckesson Corp
NYSE:MCK
101.7B USD
Loading...
US
Anthem Inc
LSE:0HG8
89.5B USD
Loading...
US
Cintas Corp
NASDAQ:CTAS
77.2B USD
Loading...
US
Amerisourcebergen Corp
LSE:0HF3
70.3B USD
Loading...
US
Cencora Inc
NYSE:COR
64B USD
Loading...
US
Cardinal Health Inc
NYSE:CAH
49.4B USD
Loading...
NA
NYSE:AAAGY
0 USD
Loading...
AU
Sigma Healthcare Ltd
ASX:SIG
36.6B AUD
Loading...
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
64B CNY
Loading...
CN
Huadong Medicine Co Ltd
SZSE:000963
63.9B CNY
Loading...
US
Henry Schein Inc
NASDAQ:HSIC
8.9B USD
Loading...

Market Distribution

Lower than 94% of companies in the United States of America
Percentile
6th
Based on 12 729 companies
6th percentile
3.5%
Low
-24 813% — 28.9%
Typical Range
28.9% — 60.5%
High
60.5% — 10 905 714.3%
Distribution Statistics
the United States of America
Min -24 813%
30th Percentile 28.9%
Median 43%
70th Percentile 60.5%
Max 10 905 714.3%

Mckesson Corp
Glance View

McKesson Corporation, with its roots tracing back to 1833, stands as a healthcare titan in the pharmaceutical industry. Founded by John McKesson and Charles Olcott in New York City, the company began its journey as an importer and wholesaler of botanical drugs. McKesson has since evolved into one of the largest healthcare companies in the world, delivering critical logistics and distribution services that underpin the healthcare sector. The company's primary role is that of an intermediary, ensuring that pharmaceutical products and medical supplies make their way efficiently from manufacturers to pharmacies, hospitals, and clinics. This pivotal position places McKesson at the heart of the supply chain, making health products more accessible and affordable across North America and beyond. The operational mechanics of McKesson are a complex yet seamless orchestration of advanced logistics, technology, and customer service. By maintaining a vast network of distribution centers, the corporation processes and ships millions of pharmaceutical products daily, ensuring they are delivered within stringent timeframes. Through its well-oiled logistics system, McKesson earns its revenue mainly from the margins on product sales and the fees it charges for its distribution services. Furthermore, the company has diversified into additional areas like healthcare technology solutions, offering software and automation systems that aid healthcare providers in managing their operations more effectively. In summary, McKesson remains an indispensable player in healthcare, translating logistical prowess into a streamlined flow of pharmaceuticals from production to patient care.

MCK Intrinsic Value
1 098.24 EUR
Undervaluation 35%
Intrinsic Value
Price
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
3.5%
=
Gross Profit
$13.4B
/
Revenue
$387.1B
What is Mckesson Corp's current Gross Margin?

The current Gross Margin for Mckesson Corp is 3.5%, which is below its 3-year median of 3.9%.

How has Gross Margin changed over time?

Over the last 3 years, Mckesson Corp’s Gross Margin has decreased from 4.7% to 3.5%. During this period, it reached a low of 3.5% on Jun 30, 2025 and a high of 4.7% on Sep 30, 2022.

Back to Top